Study finds Crohn's disease carries excess long-term mortality; ulcerative colitis does not
-
August 17
“In the modern era of IBD treatment, IBD-related mortality has fallen substantially, but important risks remain.”
BROWSE BY TOPICS
Substance use disorders in gastroenterology and hepatology: A practical guide for the general gastroenterologist
-
August 3
-
by Isabelle S. Byers, MD, Michelle Russin, MD, Sasha Deutsch-Link, MD, MSCR
GI and liver complications often bring these patients in first, and the authors say gastroenterologists are well placed to screen and treat.
Bridging the rural divide: Building a motility center in a critical access hospital
-
August 3
-
by Amber Charoen, MD, W. Michael McDonnell, MD, AGAF
“If large urban centers can run comprehensive motility labs, why can't a critical access hospital?”
Is professional coaching worth it? A practical guide for early-career gastroenterologists
-
August 3
-
by Mariam Naveed, MD, FACG, Kathryn E. Hutchins, MD, FACG
Two program directors on why coaching belongs at the start of a GI career, not after something has already gone wrong.
The Latest
Study finds Crohn's disease carries excess long-term mortality; ulcerative colitis does not
-
by Julie Greenbaum
“In the modern era of IBD treatment, IBD-related mortality has fallen substantially, but important risks remain.”
AI assistance does not improve adenoma detection in Lynch syndrome, trial finds
-
by Julie Greenbaum
“CADe can be used as an adjunctive tool, but currently available systems should not be considered a substitute for high-quality colonoscopy or careful inspection technique,” the study’s co-first author said.
Beta-blocker use at AKI onset tied to better kidney recovery in cirrhosis
-
by Doug Brunk
Patients on nonselective beta-blockers when acute kidney injury developed were more likely to recover renal function and less likely to die within 28 days, an international cohort analysis found.
UK guideline opens a no-biopsy path to celiac diagnosis
-
by Doug Brunk
Symptomatic adults in secondary care with tissue transglutaminase levels at least 10 times the upper limit of normal may forgo duodenal biopsy, but not patients seen in primary care.
Lean steatosis without metabolic risk factors tied to liver-related death
-
by Doug Brunk
“Clinicians should consider patients with steatosis but without cardiometabolic risk factors or harmful alcohol use as a distinct entity that may still carry liver-related risk.”
Esophagus
Liver
Small bowel
Stomach
Obesity
Alcohol-related liver disease
Biliary tract cancer
C. diff
Celiac disease
Colorectal cancer
Crohn's disease
Diarrhea and constipation
Diet and nutrition
IBD
Eosinophilic esophagitis
Eosinophilic GI diseases
Esophageal cancer
IBS
Infections
MASLD and MASH
GERD and Barrett’s esophagus
Hepatic encephalopathy
Liver cancer
Pancreatic diseases and conditions
Short bowel syndrome
Ulcerative colitis
Career & professional development
Diversity, equity, and inclusion
Health, wellness, and burnout
Patient advocacy and equity
Practice management
Coding, coverage, and reimbursement
Technology & innovation
Endoscopy